Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Polish journal of pathology : official journal of the Polish Society of Pathologists

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19391484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

  2008cited by this paper
• Role of matrix metalloproteinases in renal pathophysiologies.

  2007cited by this paper
• Renal fibrosis: new insights into the pathogenesis and therapeutics.

  2006cited by this paper
• Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury

  2006cited by this paper
• Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.

  2006cited by this paper
• Metzincins, including matrix metalloproteinases and meprin, in kidney transplantation.

  2006cited by this paper
• Fibrosis and matrix metalloproteinases in rat renal allografts

  2005cited by this paper
• Inhibition of Matrix Metalloproteinases During Chronic Allograft Nephropathy in Rats

  2005cited by this paper
• Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling.

  2004cited by this paper
• Angiostatin and matrix metalloprotease expression following ischemic acute renal failure.

  2004cited by this paper
• Matrix metalloproteinases as modulators of inflammation and innate immunity

  2004cited by this paper
• TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.

  2003cited by this paper
• Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.

  2003cited by this paper
• Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.

  2003cited by this paper
• A morphometric insight into glomerular and interstitial lesions in acutely rejected renal allografts.

  2003cited by this paper
• Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells

  2003cited by this paper
• Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection

  2003cited by this paper
• Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.

  2003influential reference
• Renal fibrosis: not just PAI-1 in the sky.

  2003cited by this paper
• Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA

  2002cited by this paper
• Early Human Renal Allograft Fibrosis: Cellular Mediators

  2002cited by this paper
• Late deterioration of organ transplants: a problem in injury and homeostasis.

  2002cited by this paper
• Early progressive interstitial fibrosis in human renal allografts.

  2002cited by this paper
• Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.

  2002cited by this paper
• TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).

  2001cited by this paper
• INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA

  2000cited by this paper
• Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis

  1999cited by this paper
• Extracellular matrix and the kidney.

  1996cited by this paper
• Molecular insights into renal interstitial fibrosis.

  1996cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Mechanisms of ischemic acute renal failure.

  1993cited by this paper
• Address Correspondence and Reprint Requests To

  year unknowncited by this paper

• IMPACT OF GENETIC POLYMORPHISMS IN MMPS ON THE RENAL ALLOGRAFT

  2019cites this paper
• Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.

  2017cites this paper
• Matrix Metalloproteinase-9 and Graft Preservation Injury in Clinical Renal Transplantation.

  2015cites this paper
• Clinical significance of monitoring serum level of matrix metalloproteinase 9 in patients with acute kidney allograft rejection.

  2015cites this paper
• Irreversible immunoexpression of matrix metalloproteinase‐9 in proximal tubular epithelium of renal allografts with acute rejection

  2011influential citation